Prelude Therapeutics (PRLD) Selling, General & Administrative (2019 - 2026)
Prelude Therapeutics' Selling, General & Administrative came in at $5.03 million for Q2 2026, down 21.6% from $6.41 million a year earlier and down 2.5% from the prior quarter.
Powered by 
Analysis
Prelude Therapeutics (PRLD) Selling, General & Administrative (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Prelude Therapeutics reported Selling, General & Administrative of $20.39 million, down 22.6% year-over-year; for FY2025, it was $22.41 million, down 22.0% from FY2024.
- Selling, General & Administrative has declined in each of the last three years, though with a five-year compound annual growth rate of 16.2% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $28.72 million in FY2024 (-0.6%), $28.88 million in FY2023 (-5.8%), $30.65 million in FY2022 (+13.7%) and $26.96 million in FY2021 (+154.6%).
- The five-year range for quarterly Selling, General & Administrative is $5 million (Q4 2025) to $8.15 million (Q2 2022).
- Year-over-year, Selling, General & Administrative has declined for seven consecutive quarters, with an average decline of 15.0% over the last eight quarters.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2021 (growth of 184.6%), and the weakest in Q3 2025 (a decline of 34.2%).
- Business Quant data shows PRLD's Selling, General & Administrative at $5.16 million (Q1 2026), $5 million (Q4 2025) and $5.21 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Prelude Therapeutics | 312.03 Mn | -285.27 Mn | - | 5.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.03 Mn |
| Mar 31, 2026 | 5.16 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Sep 30, 2025 | 5.21 Mn |
| Jun 30, 2025 | 6.41 Mn |
| Mar 31, 2025 | 5.79 Mn |
| Dec 31, 2024 | 6.21 Mn |
| Sep 30, 2024 | 7.92 Mn |
| Jun 30, 2024 | 7.66 Mn |
| Mar 31, 2024 | 6.93 Mn |
| Dec 31, 2023 | 7.05 Mn |
| Sep 30, 2023 | 7.12 Mn |
| Jun 30, 2023 | 7.43 Mn |
| Mar 31, 2023 | 7.28 Mn |
| Dec 31, 2022 | 7.52 Mn |
| Sep 30, 2022 | 7.52 Mn |
| Jun 30, 2022 | 8.15 Mn |
| Mar 31, 2022 | 7.47 Mn |
| Dec 31, 2021 | 7.83 Mn |
| Sep 30, 2021 | 8.12 Mn |
API Access
Prelude Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PRLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "PRLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PRLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();